Direct to Consumer Drug Advertising
Experts discuss the pro's and cons of direct to consumer advertising and its effect on patients and physicians.
Industry Funding of Clinical Trials
Funding of trials has dramatically shifted so that today, trials paid for by pharmaceutical and device makers outnumber publically funded trials 6-to-1. Some studies indicate this makes bias in trials more likely.
